PRESS RELEASE published on 05/21/2024 at 22:00, 2 years 3 months ago Inventiva publie ses informations financières du 1 ? ? trimestre 2024¹ et fait un point sur ses activités Inventiva publie ses informations financières du 1er trimestre 2024 et fait un point sur ses activités. Trésorerie de 11,0 millions d'euros, dépôt long terme à 19,1 millions d'euros. Recommandation de poursuivre l'essai clinique de phase III NATiV3. Première visite du dernier patient prévue pour le premier semestre 2024 Chiffre D'affaires Trésorerie Essai Clinique Inventiva NATiV3
PRESS RELEASE published on 05/21/2024 at 22:00, 2 years 3 months ago Inventiva reports 2024 First Quarter Financial Information¹ and provides a corporate update Inventiva reports 2024 First Quarter Financial Information and corporate update, including cash, deposits, and clinical trial progress. Company actively seeking financing options Financial Information Deposits Clinical Trial Cash Inventiva
Published on 09/16/2026 at 23:45, 9 hours 35 minutes ago Galway Metals Settles Claim by Former Employee with Cash and Share Payments
Published on 09/16/2026 at 21:30, 11 hours 50 minutes ago Torq Completes $1.7 Million Private Placement
Published on 09/16/2026 at 16:55, 16 hours 25 minutes ago CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 15:00, 18 hours 20 minutes ago 2026 Canada's Top 40 Under 40(R) Honourees Announced
Published on 09/16/2026 at 14:00, 19 hours 20 minutes ago Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update
Published on 09/17/2026 at 09:00, 19 minutes ago Encavis completes EUR 282 million non-recourse project financing for 351 MW solar PV portfolio in Italy
Published on 09/17/2026 at 09:00, 19 minutes ago Grünenthal announces pricing of €850 million of bonds
Published on 09/17/2026 at 09:00, 19 minutes ago QuE-MRT Enters Its Next Phase: Progress in Quantum-Enhanced MRI in Germany
